ロード中...
Intravitreal Ranibizumab Injection for the Treatment of Retinopathy of Prematurity
OBJECTIVES: To evaluate the efficacy of a single injection of 0.3 mg intravitreal ranibizumab for the treatment of retinopathy of prematurity (ROP). METHODS: We conducted this retrospective case series study at King Abdul Aziz Medical City, Riyadh, Saudi Arabia. Seventy-four eyes of 37 preterm infan...
保存先:
| 出版年: | Med Princ Pract |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
S. Karger AG
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6944941/ https://ncbi.nlm.nih.gov/pubmed/30995663 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000500310 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|